Seek Returns logo

COO vs. WST: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at COO and WST, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCOOWST
Company NameThe Cooper Companies, Inc.West Pharmaceutical Services, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesLife Sciences Tools & Services
Market Capitalization14.41 billion USD19.04 billion USD
ExchangeNasdaqGSNYSE
Listing DateJanuary 21, 1983March 17, 1980
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of COO and WST by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

COO vs. WST: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCOOWST
5-Day Price Return1.99%-5.12%
13-Week Price Return-1.54%6.16%
26-Week Price Return-11.78%21.07%
52-Week Price Return-29.20%-24.02%
Month-to-Date Return3.18%-7.34%
Year-to-Date Return-21.54%-20.21%
10-Day Avg. Volume1.91M0.71M
3-Month Avg. Volume2.54M0.70M
3-Month Volatility37.85%34.12%
Beta1.031.17

Profitability

Return on Equity (TTM)

COO

4.97%

Health Care Equipment & Supplies Industry

Max
29.82%
Q3
15.54%
Median
9.69%
Q1
5.19%
Min
-7.98%

COO’s Return on Equity of 4.97% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.

WST

17.33%

Life Sciences Tools & Services Industry

Max
23.81%
Q3
11.79%
Median
7.51%
Q1
3.14%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, WST’s Return on Equity of 17.33% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

COO vs. WST: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

COO

10.08%

Health Care Equipment & Supplies Industry

Max
24.65%
Q3
14.10%
Median
10.09%
Q1
5.84%
Min
-6.13%

COO’s Net Profit Margin of 10.08% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.

WST

16.29%

Life Sciences Tools & Services Industry

Max
33.77%
Q3
17.97%
Median
8.97%
Q1
3.80%
Min
-11.89%

WST’s Net Profit Margin of 16.29% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

COO vs. WST: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

COO

18.31%

Health Care Equipment & Supplies Industry

Max
31.34%
Q3
18.36%
Median
15.07%
Q1
9.62%
Min
-0.13%

COO’s Operating Profit Margin of 18.31% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

WST

19.48%

Life Sciences Tools & Services Industry

Max
31.55%
Q3
21.26%
Median
14.06%
Q1
8.54%
Min
0.11%

WST’s Operating Profit Margin of 19.48% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

COO vs. WST: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolCOOWST
Return on Equity (TTM)4.97%17.33%
Return on Assets (TTM)3.31%12.84%
Net Profit Margin (TTM)10.08%16.29%
Operating Profit Margin (TTM)18.31%19.48%
Gross Profit Margin (TTM)66.96%35.58%

Financial Strength

Current Ratio (MRQ)

COO

2.12

Health Care Equipment & Supplies Industry

Max
4.97
Q3
2.92
Median
2.12
Q1
1.54
Min
0.86

COO’s Current Ratio of 2.12 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.

WST

2.87

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.87
Median
1.75
Q1
1.37
Min
0.57

WST’s Current Ratio of 2.87 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

COO vs. WST: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

COO

0.30

Health Care Equipment & Supplies Industry

Max
1.62
Q3
0.74
Median
0.47
Q1
0.15
Min
0.00

COO’s Debt-to-Equity Ratio of 0.30 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

WST

0.07

Life Sciences Tools & Services Industry

Max
0.95
Q3
0.70
Median
0.45
Q1
0.18
Min
0.00

Falling into the lower quartile for the Life Sciences Tools & Services industry, WST’s Debt-to-Equity Ratio of 0.07 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

COO vs. WST: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

COO

5.87

Health Care Equipment & Supplies Industry

Max
56.35
Q3
24.86
Median
9.84
Q1
3.86
Min
-21.65

COO’s Interest Coverage Ratio of 5.87 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.

WST

130.12

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

With an Interest Coverage Ratio of 130.12, WST demonstrates a superior capacity to service its debt, placing it well above the typical range for the Life Sciences Tools & Services industry. This stems from either robust earnings or a conservative debt load.

COO vs. WST: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolCOOWST
Current Ratio (MRQ)2.122.87
Quick Ratio (MRQ)0.912.18
Debt-to-Equity Ratio (MRQ)0.300.07
Interest Coverage Ratio (TTM)5.87130.12

Growth

Revenue Growth

COO vs. WST: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

COO vs. WST: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

COO

0.00%

Health Care Equipment & Supplies Industry

Max
4.36%
Q3
1.87%
Median
0.82%
Q1
0.00%
Min
0.00%

COO currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

WST

0.31%

Life Sciences Tools & Services Industry

Max
1.02%
Q3
0.67%
Median
0.32%
Q1
0.00%
Min
0.00%

WST’s Dividend Yield of 0.31% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

COO vs. WST: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

COO

1.63%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
67.77%
Median
28.21%
Q1
0.00%
Min
0.00%

COO’s Dividend Payout Ratio of 1.63% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

WST

12.34%

Life Sciences Tools & Services Industry

Max
97.67%
Q3
61.34%
Median
18.53%
Q1
0.00%
Min
0.00%

WST’s Dividend Payout Ratio of 12.34% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

COO vs. WST: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolCOOWST
Dividend Yield (TTM)0.00%0.31%
Dividend Payout Ratio (TTM)1.63%12.34%

Valuation

Price-to-Earnings Ratio (TTM)

COO

35.16

Health Care Equipment & Supplies Industry

Max
67.59
Q3
41.41
Median
33.11
Q1
22.82
Min
8.68

COO’s P/E Ratio of 35.16 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

WST

40.29

Life Sciences Tools & Services Industry

Max
78.22
Q3
57.42
Median
34.18
Q1
28.39
Min
1.55

WST’s P/E Ratio of 40.29 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

COO vs. WST: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

COO

3.54

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.92
Q1
1.97
Min
0.61

COO’s P/S Ratio of 3.54 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

WST

6.56

Life Sciences Tools & Services Industry

Max
10.69
Q3
6.37
Median
4.95
Q1
3.27
Min
1.04

WST’s P/S Ratio of 6.56 is in the upper echelon for the Life Sciences Tools & Services industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

COO vs. WST: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

COO

1.69

Health Care Equipment & Supplies Industry

Max
10.77
Q3
6.04
Median
3.32
Q1
2.31
Min
0.83

COO’s P/B Ratio of 1.69 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

WST

6.18

Life Sciences Tools & Services Industry

Max
8.12
Q3
5.04
Median
3.94
Q1
2.12
Min
1.13

WST’s P/B Ratio of 6.18 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

COO vs. WST: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolCOOWST
Price-to-Earnings Ratio (TTM)35.1640.29
Price-to-Sales Ratio (TTM)3.546.56
Price-to-Book Ratio (MRQ)1.696.18
Price-to-Free Cash Flow Ratio (TTM)34.8152.25